NCT03084549View on ClinicalTrials.gov

Study of the Analgesic Effect of the Perineal Infiltration of Ropivacaine 0.75% Versus Placebo in Post-episiotomy Perineal Pain

PHASE3CompletedINTERVENTIONAL

Enrollment

272

Participants

Timeline

Start Date

October 24, 2017

Primary Completion Date

November 4, 2020

Study Completion Date

November 4, 2020

Conditions

Episiotomy

Interventions

DRUG

Administration of Ropivacaïne

Administration of Ropivacaïne in the margins of the episiotomy

DRUG

Administration of placebo

Administration of placebo in the margins of the episiotomy

Trial Locations (2)

44093

Centre Hospitalier Universitaire Nantes, Nantes

85925

Centre Hospitalier Departemental Vendee, La Roche-sur-Yon

All Listed Sponsors

lead

Centre Hospitalier Departemental Vendee

OTHER

NCT03084549 - Study of the Analgesic Effect of the Perineal Infiltration of Ropivacaine 0.75% Versus Placebo in Post-episiotomy Perineal Pain | Biotech Hunter | Biotech Hunter